ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000719.1|Tobramycin_2 # 1372 # 2472 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.728	BGC0000719.1|Tobramycin_2 	1372	2472	+	Loose	300	26.9498	tet(36)	47.62	3000197	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGTTTGGCGACGCGACCCTGCCCCTCGCTCCCGTCGCCACGCGTCCTTTGGTGTGCACGCCAGGACTTGGGGGTCGTCGCGTGAAGGCACTGACGTTCGTAGCGCCCGGCGAGGCGGTCTTCGGCACCCGCGCGGTGCCCGTCCCCGCCCCCGGTGAGGCGCTGGTCCGCCTCGGGTACAACTCGATCTGCGGCAGCGACCTGTCGCTGTACCGGGGCGTCTGGCACGGATTCGGCTACCCGGTCGTGCCGGGTCACGAGTGGAGCGGGACGGTCGTCGAGGTCAACGGGCCCGGCGACGAGTTGGTCGGCCGGGACGTGGTCGGCGACCTCACGTGCCCGTGCGGCGCGTGTGCCGCCTGTCAGCGCGGGACTCCGGTGCTCTGCGAGAACCTCCAGGAACTCGGGTTCACCCGGGACGGCGCGTGCGCGGAGTACATGACCATCCCGACGCGCAACCTGCACCGGCTGCCGGCGGAACTGTCGTTGCGGGTCGCCTGCCAGGTGGAGCCGGTCGCCGTTGCCCTGCACGCTCTGTCCACTGTGGACGTCTCGCCCGGGGAGAAGGTGGCCGTCCTCGGCGCCGGCGGGATCGGCCTGCTGTTGTCACAGGTGGCGCGACACCGGGGCGCGGTGATCACCACCGTCGGCGAGCCCGTCCCCGAGCGCAGGGCGGTCGCCGCCCAGCTCGGGGCGGCGACGGTGACGACCGGCCGCCCCGGCGAGCTGGCGGACCTGGTGGCCAAACGCCCGGAGCTGACCCCCGACGTCGTGCTGGAGGCCTCCGGCTACCCGGTCGCCCTGCAGGAGGCGATCGAGGTCGTGCGCCCCGGCGGCCGGATCGGCGTGGTGGGCTACCGGGTCGAGGAGATCAGCCCGATGGCGACCCACCACGTCGCCGTGAAGGCGTTGACGATCCGGGGCTCGCTGGGGCCCGGCAACCGGTTCCCCGACGCCATCGACCTGCTCGCTCGGCGCGAGATCAACGTCGATCCGCTGCTCAGCCACGAGTTCGCGCTGGCCGACCACGCCCGCGCGCTGGAGCTCGCGTTGCGCCGCACCGAGGGCAACATCCGCTCGTTCTTCAACCTCCGCGCCTGA	MFGDATLPLAPVATRPLVCTPGLGGRRVKALTFVAPGEAVFGTRAVPVPAPGEALVRLGYNSICGSDLSLYRGVWHGFGYPVVPGHEWSGTVVEVNGPGDELVGRDVVGDLTCPCGACAACQRGTPVLCENLQELGFTRDGACAEYMTIPTRNLHRLPAELSLRVACQVEPVAVALHALSTVDVSPGEKVAVLGAGGIGLLLSQVARHRGAVITTVGEPVPERRAVAAQLGAATVTTGRPGELADLVAKRPELTPDVVLEASGYPVALQEAIEVVRPGGRIGVVGYRVEEISPMATHHVAVKALTIRGSLGPGNRFPDAIDLLARREINVDPLLSHEFALADHARALELALRRTEGNIRSFFNLRA	MRTINIGILAHIDAGKTSITENLLFASGATIVRGSVDKGNTTTDSMDIEKRRGITVRASTTSIQWNDTKINIIDTPGHMDFLAEVERTFRMLDGAILVVSAKEGIQAQTRLLFNVLQQLEIPTILFVNKIDREGVNLNQLYLEIQNSLSKDIIFMQSVEGKELTSSCTIHYISEKNRETILEKDDLLLEKYLSDTQLSNLDYWNSMVRLVQAAKLHPIYHGSAMYGIGIEDLLNSITTFIETSLPQENALSAYVYKIEHNKKEQKRAYLKIIGGTLKSRKLYSLNGSDENLKIRGLKTFYSGDEIDVDEVFTNDIAIADHADNLMVGDYLGIMPNLFDKLNIPSPALKSSIHPAKVENRSKLISAMNVLSVEDPSLAFSINADNNELEVSLYGATQREVILTLLEERFSVDAYFEEVKTIYKERLKTKSEYTIHIEVPPNPYWASIGLIIEPLPIGAGLVMESEISLGYLNRSFQNAVFDGVKKACESGLYGWEVTDLKVTFSHGIYYSPVSTPADFRSLAPYVFRLALQQADVELLEPILDFKLQIPLAVNARAITDINKMQGEISTITSDGDWTTILGNIPLDTSKEYSAEVSSYTQGLGVFVTRFSGYRPTNKKVSRSVELNEKDKLMYMFEKESIK	57.19	gnl|BL_ORD_ID|1675|hsp_num:0	1708			909	972	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000719.1|Tobramycin_3 # 2582 # 3880 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.745	BGC0000719.1|Tobramycin_3 	2582	3880	+	Loose	800	41.5874	tetA(P)	26.58	3000180	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTCTCAGCATGCCGCGTCCGCAGACGAAACATCGGCCGGGGCGCCCGCCGCCGACCCGAGCCCCGAATCCCGGGCGCGGGCCAGGGCGACGGGCCGGCGACTGCGCCTGTTCTTCGGGCTGCACGAGCTGGTCCCGCTCTTCCCGCTCTACCCGCTGCTGTTCGCCGACCACGGGCTGTCCACCGCGGGGATCTCCGGGTTGCTGGCCCTCTGGTCGGTCACGGCCTTCGTCCTGGAGGTGCCCTCCGGGGTCCTGGGCGACATGTTCTCCCGCCGTTGGCTGCTCGCCGTCGGCACCGCCGTGCGGGCCTGCGGTTTCGGCCTGTGGGTGGCTTTCCCGTCGCCGTGGGCCTTCGCCGCCGGGTTCCTGTGCTGGGGCCTGTGCGACGCGCTGACCTCGGGAACGCTGGAGTCGCTGATCTACGACGAGCTGCGCGCGGCCGGCGCGTCCCACCGGTACGCGGCGGTGATGGGCAGCGGCCGGGCGGTGTCCCTGCTCTCCACGCTCACCGCGATGACGTTGGCCGGGCCGGTCTTCGCGCTCGGCGGCTACCCGCTCGTCGGGATGATCAGCCTGGGCAGCGGGCTGGCCTGCGCCGTCGCCGCGCTGCGGTTCTCCGAGCCGCCCCGGGACCAGGTCGGGCGGGAGGACGGCGGGTTGCGTTGGTACGTCGCGACCTTCCGGGCCGGGGTGTCGGAGGTGCGGCGGGACCGGGTGGTGCTGCGCGCGGTGCTCATCGCCGCGTCGCTGCACAGCATGACGGCCATCGACGAGTACTTCCCCATGCTGGCAAGGGCGAACGGCGCGTCGACGACGATGGTTCCGGTGCTGGTGGCCGTGACGGTCGTCTGCGCGGCGGCCGGCAGCGGTCTGGTCGGCAGGACCGCGCACGCCCCGCCCGCCGTGCTGGGCCTCGCCCTGCTGGCCTCGGCCGGGCTGATGGTGGCGGGCGCGCTGAGCGGGCTCCAGGCGGGCATGCTCGCCGTCGGGGTGAGCTTCGGCCTGGTGCAGTGGGCGCTGGTGCTGGCCGACACGCGGTTGCAGGACGCGATCACCGGTCCGGCGCGCGCGACCGTCACCTCGGTCGTCGGGTTCGGCGCCGAGGTGGCCTCGGTCGGCTTCTACCTGGGCGCCGGCGCTCTCTCCACCGTCACCTCCACGTCCGAGCTGTTGGCCTGGTTCGCGGTGCCGCTCGTCCTCATCGCGGTGGCCGCCCCGCGCTGGTTGAGACGGGAACCGCAGCCGCCCGGCGAGGTTCCCCGGGCGCCGGGAGCGGAACCACCGCGGCCTGCCTGA	MSQHAASADETSAGAPAADPSPESRARARATGRRLRLFFGLHELVPLFPLYPLLFADHGLSTAGISGLLALWSVTAFVLEVPSGVLGDMFSRRWLLAVGTAVRACGFGLWVAFPSPWAFAAGFLCWGLCDALTSGTLESLIYDELRAAGASHRYAAVMGSGRAVSLLSTLTAMTLAGPVFALGGYPLVGMISLGSGLACAVAALRFSEPPRDQVGREDGGLRWYVATFRAGVSEVRRDRVVLRAVLIAASLHSMTAIDEYFPMLARANGASTTMVPVLVAVTVVCAAAGSGLVGRTAHAPPAVLGLALLASAGLMVAGALSGLQAGMLAVGVSFGLVQWALVLADTRLQDAITGPARATVTSVVGFGAEVASVGFYLGAGALSTVTSTSELLAWFAVPLVLIAVAAPRWLRREPQPPGEVPRAPGAEPPRPA	MVNKLSAYKTYLLFSAITAMCFSLVATVMMVYHIEIVHLNPLQLILVGTTLELACFIFEIPTAIVADVYSRKLSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWIAEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLYMPENNFKPSAPGDLNTFKKMVYTFKSGLKFVKSKSIIMILLAVTLFYGLSSEGYDRLSNAHFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINILYISSMLIFALTRNFSLMLIAYLATNTFRIINKPIFSAWLNGHIDDNSRATVLSINGQMNSLGQILGGPIIGIIATNISVSIGIVCTSLLVTPVLVLYIVAMIIDKKVDDRVGGIDYEENN	102.86	gnl|BL_ORD_ID|467|hsp_num:0	508			162	399	tetracycline
BGC0000719.1|Tobramycin_4 # 4057 # 5244 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.711	BGC0000719.1|Tobramycin_4 	4057	5244	+	Loose	400	26.9498	salE	30.56	3007029	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	ATGACCCAGACCAACGAGATCAGCGCGACGACGGGGGACTGGAGCCGGTCCGCCGAGCACCTGCGCCGGTCCCACGAGGTCACCACCAACCCCCGTCCCGACCAGGACGGCCAGTTCCCCTGCGTGCTCTCCAGGGGCGCGGGGGCGCGCGTGTACGACCTGGACGACAACGCCTACTTCGACCTCACCTGCTCGTTCGGCACCGTCCTCATCGGACACGCCGAGCCGGCCGTCACCGACGCGATCCGGGCGAGCCTGGACGACGGGAACCTGTTCTACACCGGGCCGAGCCCGCGCCGGCTCGCGCTGGCCGAACGCCTGCTCGACTGGTTCCCCTGGGCCGACCAGGCGTTGTTCTACCGGACCGGGTCCTGCGCGGTCTCCGCGGTCGCCCGGCTCACCCAGCACGTCACCGGCCGGACGACCGTGCTCACCTCGGGCTACCACGGCTGGCATGACTGGCACCTGGAGGCGGTGCCGGAGGCCAAGCTGTTCCCGTCCTACGCCACCGAGTTCCACGAGGACCTCGACGTCTACCGCGCCTACCTGGAGCGGCACGCGGACGAGATCGCCGCCGTGGTCGTCACGCCGGAGCCCACGCGGAAACCGGTGGGCCACTACCGCGTTCTGCGCGAGCTGGCCGCCGAGCACGGCTGTCTGTTCGTGGTGGACGAGGTGAAGACGGGCATGCGCGCGGGGAAGGGCGGGCTCAGCGCCCTCGCCGGGCTGGAACCGGACGCGGTGACCGTCTCCAAGGGACTGGCCAACGGGCACAGCATCTCCGCCGTGGTGGGCAGCCGCCGGATCACCGACGGCCTCGACGAGGCCCACGTGTGGTCCACGTACCAGAACGAGCAGGTGGGCTTCGCCGCCGCACTGGCCACTGTGGACTTCCTGGAGAGCCAGGACGTGGCCGCGGTCGTCGGACGCACGGGACGCGTGGTGGAGCAGGCGTTCCGGAGCGCGTTCGCCGAACGGGGCCTCCCGGTGGAGGTGCGCGGCTGGGGCCCGATGTTCGACCTCGACTTCTCCGCTGCCGAGGAGGGACTGGCCGACCGCCTGCAACTCGCCTTCCTCCGCCACGGCGTCTTCTGCGACATCGGCGACGACTTCAACGTCATGTACCGCACCGCCGACCACCTCGACGAGCTGACCGGGCGGGTGACCGCGGCGATCAGGTCGGTCTGA	MTQTNEISATTGDWSRSAEHLRRSHEVTTNPRPDQDGQFPCVLSRGAGARVYDLDDNAYFDLTCSFGTVLIGHAEPAVTDAIRASLDDGNLFYTGPSPRRLALAERLLDWFPWADQALFYRTGSCAVSAVARLTQHVTGRTTVLTSGYHGWHDWHLEAVPEAKLFPSYATEFHEDLDVYRAYLERHADEIAAVVVTPEPTRKPVGHYRVLRELAAEHGCLFVVDEVKTGMRAGKGGLSALAGLEPDAVTVSKGLANGHSISAVVGSRRITDGLDEAHVWSTYQNEQVGFAAALATVDFLESQDVAAVVGRTGRVVEQAFRSAFAERGLPVEVRGWGPMFDLDFSAAEEGLADRLQLAFLRHGVFCDIGDDFNVMYRTADHLDELTGRVTAAIRSV	MSFYFAQKPFEMFGKTLIQSVDLQFEKGEHIAVIGNNGVGKTTLLKALNNKYKEDTYLMDQNMTTFGNMTGIDYVISLNTELFHLKQALMDNYEKVSDYIALNGYEFEQTIITKAKQMALTEADLDKPIKVLSGGQQTRLALLRAFISNKPLILLDEPTNHLDQEMIDQLINHIQQSKRTIIYVSHHRGFIDQTASHVIEITPESTRKFNGNYKQYKEIKDLESQTEQRIYNKQQKEIQDLERTIKRVQTWHHSAQQKASVRNPIEQKKLSKLAQRAKVKEKQLNQKLQEKHIQEPSKETKSYYFSHQTSLPKRFLIRFEDVSVNIDGQAIYKHAHFEMKQNENILLTGPNGSGKSLFIALIRQHLSPDEGIIEITPSLKIGYFDHTNNNLNEAESPLSMLLVRTNITRSQAQTLLASFNFDKDQIKKPIRYLSMGEKSRLQFVLLYFSGANLLVLDEPTNYFDIVTQDLILSMIQSFTGQVLIVTHDSYLQSQFKAVHWEIKNQQLYNVSLTHTRESNLDETLKLLGEYKFIDENGHFETDN	72.74	gnl|BL_ORD_ID|4728|hsp_num:0	5740			558	660	tiamulin; retapamulin
BGC0000719.1|Tobramycin_5 # 5297 # 6823 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.726	BGC0000719.1|Tobramycin_5 	5297	6823	+	Loose	1800	28.8758	mexY	31.75	3003033	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTGCTGATCTCACCGGACGAGGCCGCGCGTCGGACCTACGACGCCTGTGTCATCGGCAGCGGCGCCTCCGGCTCCGTGGCCGCGGCCGTGCTCGCCGAGCGCGGTCTGTCGGTGCTCGTGGTGGAACAGGGCGGCCCGATCCCGCCGGGCGCCGACGGGGAGGACCACGAGGACCCCGACGGGTGGGCGTTCGCGCGCCGCGACGGGCGCTGGACCCGGGACGGCTACCCGTGGACGGCCATGGCGCTCGGCGGGGGAACCCTGTTCTACGCCGGGATGTCCTACCGCTACCAGCAGACCGACCTGGCCCCGCCCTCGTCGTTCCTCGGCGCCGCCGACTACGACCACTGGCAGGTCGGCCTCGCCGACCTCGAACCGCACTACGAGTGGATCGAGTACCAGCTCGCGATCGCCGGCCCCTCCAGGAAACAGGTGGGCGACTACGTCTTCCCCGTCTACCACCGGCCGAGCCTGCCGCTCACGCCGCCCGGCGCGGCGCTGGCCGAGGGCGCTCGCTCGCTCCACCTCACGCCCCTGCCCACCCCGGTGGCGATCAGCGGGGTGCGGGACCGGTTCGGCCCCGGCTGCGCCCAGACCACCCCGTGCACCTCGTTCTCCTGTCCCACGAAGGCCAAGGCCGACGTCGTCAGCCGGGTTCTCGCTCCCGCCGAGGGAGACGTCTCGGTGGTCGTCCACACCAGAGTCGTCCGGCTCGTGGCGTCGAGTCCGCACCGGGTTGACGCGGTCGAGGTGCTCGACCGCGAGAACGGCACGCGCCTGACCCTGCGCGCCCGTCGATTCCTGTTGGCCGCCAACGCGATCCAGTCCGCCGCGCTGCTGCTCCGGTCGACAACCCGCACCGAGCCGGACGGGATCGGCAACCGGCACGGGCTCGTCGGGCGGCACCTCGCGATGAAGAACAGCGTGTACGTGCGCGGGACCATCCCGCGCAGACTGCCCGGGTACACCCCGTTGCGACACCGGTACTCCAGCGTCTGCGTGTTGGACTTCCTCACCGGAGAAGCGTTTCCCGACGGAATCGGCGGACTGATCCACGAGGCCAACCCGTGGGAGCCCGCCGCCGAGCGGGAGGCGGCCCGCGGCACCCTGTTGCAGGTCGAGTGCCTGGTGGGCGACCGGCCCCAGGCCGAGAACCGGGTTCGGCTGTCCCGGACCCGGGACCGGGACGGCCTTCCCCGCATCGTCATGGACTACCGGCCGCACCCCGCCGACCTCCGGCGCTTGGCCGTGTTGTCCGAGCGCGCCCACGACATCCTCACCAAGGCCGGCGCCGTCGACGTGCGCGAGGTGGACACCGCCTACGAGTTGGGCAGCGCGCACCTGCACGGAACCCTGCGCGCCGGCCGAGACCCCCGCACGTCGGTGACCGACCCGTTCGGCCGCCTGCACGACCACGACAACGTCTGGTCGGTCGACGGCGCCACGTTCCCGTTCGCCGGCAACCCCAATCCCACCCTCACCATCCAGGCCAACGCCCACCGGATCGCGCTCGCGATCGACTGA	MLLISPDEAARRTYDACVIGSGASGSVAAAVLAERGLSVLVVEQGGPIPPGADGEDHEDPDGWAFARRDGRWTRDGYPWTAMALGGGTLFYAGMSYRYQQTDLAPPSSFLGAADYDHWQVGLADLEPHYEWIEYQLAIAGPSRKQVGDYVFPVYHRPSLPLTPPGAALAEGARSLHLTPLPTPVAISGVRDRFGPGCAQTTPCTSFSCPTKAKADVVSRVLAPAEGDVSVVVHTRVVRLVASSPHRVDAVEVLDRENGTRLTLRARRFLLAANAIQSAALLLRSTTRTEPDGIGNRHGLVGRHLAMKNSVYVRGTIPRRLPGYTPLRHRYSSVCVLDFLTGEAFPDGIGGLIHEANPWEPAAEREAARGTLLQVECLVGDRPQAENRVRLSRTRDRDGLPRIVMDYRPHPADLRRLAVLSERAHDILTKAGAVDVREVDTAYELGSAHLHGTLRAGRDPRTSVTDPFGRLHDHDNVWSVDGATFPFAGNPNPTLTIQANAHRIALAID	MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA	48.57	gnl|BL_ORD_ID|1640|hsp_num:0	1786			2271	2448	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0000719.1|Tobramycin_6 # 6874 # 8586 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.722	BGC0000719.1|Tobramycin_6 	6874	8586	+	Loose	900	28.8758	adeH	28.0	3000779	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTGTCCTCGGACTGAACGGCTGGCCCCGCGACTTCCACGACGCGTCGGCGGCCCTGCTCGTCGACGGCCGGATCACGGCGTTCGCCGAGGAGGAGCGGTTCACCAGGAAGAAGCACGGGTACGACACGGCTCCCGCGCAGGCGGCGGCGTTCTGCCTGGCCCAGGCGGGCCTGACCGTGGACGACCTGGACGCCGTGGCCTTCGGCTGGGACCTGCCCAGGATGTACCGCGAGCGGCTGGGCGGCTGGCCGCACTCGGACAGCGAGGCGCTGGACATCCTGTTGCCCCGGCACCTCTTCCCCCGGCGCACCGACCCGCCGCTGCACTTCGTCCAGCACCACGTGGCGCACGCGGCCAGCGCCTACCACTTCTCCGGCGTCGACCACGGCGCGGTGCTGATCGTGGACGGCGAGGGCGAGGAGGAGTGCGTCACCCTGGCCCGGGCCGAGGGCGGGAAGATCACCGTGCTGGACACCGTCCCCGGTGCGTGGTCCCTGGGCTTCTTCTACGAGTCGGTCAGCGAGTACACCGGCCTGGGCGGCGAGAACCCCGGCAAGCTCATGGGACTGGCCGCGCACGGGACCGCGGCGGACGAGACGATGTCCACCTTCGCCTTCGAGCCGGACGGTTACCGGCTCGGCCTGCTCGACCCGGACGCGCGGGACCCGGAGGACTGGGACGAGTACTACCTGACGCAGCGGGCGTGGTTCGCGCACCTGGAGCGGACGTATCGCTTGCCCCCCAACGAGTTCGTCCACCGCTACGACCCCGCCAAGGGGCGGGTCGTGCGGGACACGCGACGGGACCCCTACGAGTACCGGGATCTGGCGGCCACCGCCCAGGCGGCGTTGGAGCGCGCGGTGTTCGGGCTGGCCGACTCGGTGCTCTCCCGCACGGGAGAGCGCAGTCTGTTCGTCGCAGGCGGTGTCGGTCTCAACGCGACCCTGAACGGCAAGCTGCTGACGCGGTCCACTGTGGACCACGTGTTCGTTCCCCCGGTGGCCAGCGACATCGGCGTGAGCCTCGGCGCGGCGGCGGTGGTCGCCGTCGAGCTCGGCGACCGCATCGCGCCCATGGGCGACACCGCCGCCTGGGGACCGGAGTTCTCCCCGGACCACGTGCGGGCCGCGCTCGACCGCACCGGCCTGTCCTACCGGGAGCCGGCCAACCTGGAGCGGGAGGTCGCCACGCTCGTCGCCGACGGCAAGGTGGTGGGCTGGGCGCAGGGCAGGGCCGAGGTCGGCCCGAGGGCGTTGGGCCAGCGCAGCCTGCTGGGCTCCGCGCACTCCCCGACCATGCGCGACCACATCAACCTGCGGGTCAAGGACCGGGAGTGGTGGCGTCCGTTCGCCCCCAGCATGCTGCGCTCGGTCAGCGACCAGGTGCTGGAGGTCGACGCCGACTTCCCCTACATGATCATGACGACGAAGGTGCGCGCGGCCTACGCCGAGCGCCTGCCGTCGGTGGTGCACGAGGACTGGTCGACCCGCCCGCAGACCGTGACCGAGGCCGGGAACCCGCGCTACCACCGGATGCTCACCGAGCTCGGCGACCTGGTCGGCGACCCGGTCTGCCTCAACACCTCCTTCAACGACCGGGGCGAACCCATCGTCTCGTCGCCGGCCGACGCCCTGCTCACCTTCGCCCGCCTGCCGATCGACGCCCTGGCCGTCGGCCCGTACCTGGTGACCAGGGACCTCCGCCACTAG	MRVLGLNGWPRDFHDASAALLVDGRITAFAEEERFTRKKHGYDTAPAQAAAFCLAQAGLTVDDLDAVAFGWDLPRMYRERLGGWPHSDSEALDILLPRHLFPRRTDPPLHFVQHHVAHAASAYHFSGVDHGAVLIVDGEGEEECVTLARAEGGKITVLDTVPGAWSLGFFYESVSEYTGLGGENPGKLMGLAAHGTAADETMSTFAFEPDGYRLGLLDPDARDPEDWDEYYLTQRAWFAHLERTYRLPPNEFVHRYDPAKGRVVRDTRRDPYEYRDLAATAQAALERAVFGLADSVLSRTGERSLFVAGGVGLNATLNGKLLTRSTVDHVFVPPVASDIGVSLGAAAVVAVELGDRIAPMGDTAAWGPEFSPDHVRAALDRTGLSYREPANLEREVATLVADGKVVGWAQGRAEVGPRALGQRSLLGSAHSPTMRDHINLRVKDREWWRPFAPSMLRSVSDQVLEVDADFPYMIMTTKVRAAYAERLPSVVHEDWSTRPQTVTEAGNPRYHRMLTELGDLVGDPVCLNTSFNDRGEPIVSSPADALLTFARLPIDALAVGPYLVTRDLRH	MVITSKQNWLLSSLMGSLLLAGCSLAPEYQPAKVIVPVKFKESDPKLEDNNWKIAQPADQQTRGEWWRIYNDAQLNELEQQAIAGNQNLKAVAANIQASRALRSAAQAERLPSIDAGFGPTRQKPSPASLGLDDNAHTSAQTLWRAQANVSYELDLFGRVASSVNAATADLQQQEALYQSALLALQADVAQGYFLIRQLDTEQAIYNRTIKLLGETRDLMQLRFKNGLVSELDVSRAQTELATAQTTALNIARNRASAEHALAVLLGKPPADFNLAVQPLTANSIRLPAGLPSTLLERRPDIAAAERAMAADNARIGIARAAFFPKLSLTGALGYESSSLSELGKWSSRTFLLGPVAGTILSLPLFDGGQRKAGVAQARAAYEESVANYRQTVLNAFREVENGLSDQRILDQQIQAQNQALSSSRHANQLSHLRYREGAISYLDVIDSDRTILQQEQLAAQLKGSQIIASINLIRALGGGWSS	118.01	gnl|BL_ORD_ID|493|hsp_num:0	542			192	342	tetracycline
BGC0000719.1|Tobramycin_7 # 8697 # 9971 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.736	BGC0000719.1|Tobramycin_7 	8697	9971	+	Loose	920	27.7202	OpmD	34.15	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCCCGTCCACCTCGCGATCAACAACGGAACCCCGGTGCGCACCCGGCCCTGGCCGGTCTGGCCCCAGCCGGCCCGGGGCGCGCTCGGCGCGCTGGAACGCGTGCTCCACTCCGGACGCTGGGCGATCAGCGGCCCCTACCGGGGCGCCGAGTCGGCCGAGCGCCGCTTCGCCAGGACCTTCGCCGCCTACAACGGGGTCGCGCACTGCGTCCCCGCGGCCAGCGGCACCGCCAGCCTCATGCTCGCGCTGGAAGCCTGCGGCGTTGGCGTCGGCGACGAGGTCATCGCCCCCGGACTGTCCTGGGTGGCCTCGGCCTCCACCATCGTCGGCGTCAACGCCGTCCCGGTCCTCGTCGACATCGACCCCGCGACCCTGTGCCTGGACCCGGCCGCGGTCGAGGCGGCGATCACGCCTGCCACCAGGGCGATCGTCGTCGTGCACCTGTACTCCGCGGTGGCCGACCTGGACGCGCTGCGCGGCGTCGCCGACCGGCACGGCCTGCCGCTGATCGAGGACTGCGCCCAGGCCCACGGCGCCGAACACCGCGGCCGTAAGGTCGGCTCGGTCGGCGACATCGGGACGTTCAGCATGCAGCACAGCAAGGTGCTCACCAGCGGGGAGGGCGGAGCCGCGATCACCGACTCCGCCGCGCTGGCCCGCAGGATGGAACACCTGCGCGCCGACGGCCGCTGCTATCCCGCCGCCGCGCCCGCGCCCGGACACATGGAACTGGTCGAGACCGGGGAGCTGATGGGCAGCAACCGGTGCCTGTCGGAGTTCCAGGCCGCCGTGCTCGTCGAGCAGCTCAGGGAACTCGACGAGCAGAACGCCCTGCGCCGTCGCAACGCCCTGCTGCTCAACGAGCTTCTCGCAGAGCAGGGGCTGCGGCCGCAGGACAGCTCGCCAGGCACCACCAGCCGCACGTACTACGTCTACGCCGCCGCCCTGCCCGACGACGCGCTGACCGACGTCCCGATCGCCGCCGTGACCGGGGCGCTCACCGCCGAGCTGGGCTTCCCGATCTCACCGGCCTACGCGCCACTGCACACCAACCGGCTCTACGCGCCGGCCTCCCGCCGCCGGTTCGCGCTCGGCGACGAGCACGAGAAGCGGATCGACCCCGGCCGGTTCCACCTGCCGGTGTGCGAGCGGCTCACCCGCCGCCTGATCACCTTCCACCACGCCGCGTTGCTCGGCGACGAGTCCGACGTGCGCGACATCGCCACCGCCGTCGCCAAGGTGCTGCGGCACCGCGGGGAGCTGCGGGCTTGA	MPVHLAINNGTPVRTRPWPVWPQPARGALGALERVLHSGRWAISGPYRGAESAERRFARTFAAYNGVAHCVPAASGTASLMLALEACGVGVGDEVIAPGLSWVASASTIVGVNAVPVLVDIDPATLCLDPAAVEAAITPATRAIVVVHLYSAVADLDALRGVADRHGLPLIEDCAQAHGAEHRGRKVGSVGDIGTFSMQHSKVLTSGEGGAAITDSAALARRMEHLRADGRCYPAAAPAPGHMELVETGELMGSNRCLSEFQAAVLVEQLRELDEQNALRRRNALLLNELLAEQGLRPQDSSPGTTSRTYYVYAAALPDDALTDVPIAAVTGALTAELGFPISPAYAPLHTNRLYAPASRRRFALGDEHEKRIDPGRFHLPVCERLTRRLITFHHAALLGDESDVRDIATAVAKVLRHRGELRA	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	87.06	gnl|BL_ORD_ID|450|hsp_num:0	442			699	915	acriflavine; tetracycline; norfloxacin
BGC0000719.1|Tobramycin_8 # 10001 # 11161 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.714	BGC0000719.1|Tobramycin_8 	10001	11161	+	Loose	700	28.1054	ADC-223	25.26	3006392	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	ADC beta-lactamases pending classification for carbapenemase activity	ATGCAGACCACCACCATCACCATGGGAGACGTCCACTACCCGTACCGGCTCGGCACCGGCTGCGTCGACGCGGTCGTCGACCGGCTGGGCGAGCTGGGCGCCAGCCACTACCTCGTGCTGTGCGACGCGACCGTCGCCGAGCTGTACGGGAATGACCTCGTCGCACGCCTGAACCGCGCGGCCGGGCCGGCCACCGTCCTGGTGCACCCGGCGGGGGAGGAGCACAAGGGGCTCGGCACGCTGAACACCCTCGCCGACGCCGCTCTCCACGCCGGAGTCGACCGGCGGGGACTGGTCGTCGCGCTGGGCGGCGGTGTCACCGGGAACATCGCCGGTCTGCTCGCCGCCCTGCTGTTCCGCGGGATTCGCCTGGTGCACGTGCCGACCACGGTCGTGGCGATGCTCGACTCGGTGCTGTCGTTGAAACAGGCCGTCAACGCCCAGGTGGGCAAGAACCTCGTCGGCACCTTCTACCCGCCGGTCGAGGTGCTCGCCGACACCGCGGTGCTGAACACCCTGCCGGTCAGGGAGATCCGGTCGGGGCTGTGCGAGGTCGTGAAGAACGCGTTGGCGATCCGGCCCAGCATGATCTCCTTCCTGGCCGCCGAGCTGCGACCCGACGGCCGCTACGCCGACGACGTCCTGCGCTGGATGATCGACGAGAGCATCGCGGCGAAGGCCCAGGTCACCGAGCACGACAAGTACGAGCGGCGGGAGGGCCTGGTCCTGGAGTACGGCCACACCGTCGGCCACGCCCTGGAACACGCCTCGCACGGCGCGGTGTCGCACGGCGCCGGCGTCGGGCTGGGAATGGTCGCCGCCGCCCGGGTTTCGCACCGCCTCGGGCACGTCGACGCCGGTTTCGCGGAGCTGCACCGGGAGTTGGTGAGCAAGGTCGGCGTCGCGACGACCGTGCCGACCAGCGTTCCGCACCAGGAGATCACCTACCGGCTCGGCTTCGACAACAAGCGGGGGTACCAGTCCCTCGCCGCCGACCAGTACGCGATGGTCCTGCTGGAGGGCGCTGGCCAACCGCTGCGCCGCGACGGCCTGCCACTGACACCGGTGCCCAGAGCCCTGGTCGACGAGGTCGTGCGGGAACTGGCCGGTGTCCCGTCGCGCGTCGGCGCGTCCGTCGCCACCGCGGGGGGTGCGTCGTGA	MQTTTITMGDVHYPYRLGTGCVDAVVDRLGELGASHYLVLCDATVAELYGNDLVARLNRAAGPATVLVHPAGEEHKGLGTLNTLADAALHAGVDRRGLVVALGGGVTGNIAGLLAALLFRGIRLVHVPTTVVAMLDSVLSLKQAVNAQVGKNLVGTFYPPVEVLADTAVLNTLPVREIRSGLCEVVKNALAIRPSMISFLAAELRPDGRYADDVLRWMIDESIAAKAQVTEHDKYERREGLVLEYGHTVGHALEHASHGAVSHGAGVGLGMVAAARVSHRLGHVDAGFAELHRELVSKVGVATTVPTSVPHQEITYRLGFDNKRGYQSLAADQYAMVLLEGAGQPLRRDGLPLTPVPRALVDEVVRELAGVPSRVGASVATAGGAS	MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK	101.05	gnl|BL_ORD_ID|3221|hsp_num:0	4288			756	1026	
BGC0000719.1|Tobramycin_9 # 11158 # 11715 # 1 # ID=1_9;partial=01;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.742	BGC0000719.1|Tobramycin_9 	11158	11715	+	Loose	400	26.1794	vanR gene in vanI cluster	38.89	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGAGCGCGCCGCTGGGAGTCGCCGTGGTGGGCGCCGGGTTCATGGGCGGTGTCCACGCCGAAGTGCTCGCCGCGCACCCGCGTGCCCAGCTCGTCGCGGTCTGCGACCTCGACCAACGGGCCGCCCAGGAGTTGGCCGGGCGGTTCGCCGTTCCGACGGTCACCGACGACCTCGACCGCGTCCTGGCCGACGACCGGGTCGGCCTGGTGGTGGTGACGACCCCGAACGCGCTGCACGCCGACCAGGCGGCCCGGGCGTTGCGGGCCGGCCGACACGTGTTGGTCGAGAAACCCCTCGCCCTCACCCCGGACGAGATCCACGGGCTGCTGCGGCTGGCCACCGAGCGCGGCCTGGTGCTGGCGCACGGCAGCAACTTCGTGCAGAGCCCCAAGTTCCGCCGGGTTCGGGAACTGGTCGCCGACGCGGAGGCGTTCGGCACGCCCCACCTGGCCCGGGTCGTCGTGCGCAACGCGGGACCGGACTCCGGGTGGTGCCTGGACCCGGCGCTCGCCGGTGGGGGAGTGCTGCTCGATCTCGGTTGCCACGCCGTGGAGATC	MSAPLGVAVVGAGFMGGVHAEVLAAHPRAQLVAVCDLDQRAAQELAGRFAVPTVTDDLDRVLADDRVGLVVVTTPNALHADQAARALRAGRHVLVEKPLALTPDEIHGLLRLATERGLVLAHGSNFVQSPKFRRVRELVADAEAFGTPHLARVVVRNAGPDSGWCLDPALAGGGVLLDLGCHAVEI	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	80.17	gnl|BL_ORD_ID|2065|hsp_num:0	2246			447	555	vancomycin; teicoplanin
